Silence Therapeutics (SLN) Net Income (2024 - 2026)
Silence Therapeutics (SLN) reported Net Income of -$15.0 million for Q1 2026, up 47.57% on a YoY basis from -$10.1 million in Q1 2025, and down 27.08% sequentially from -$11.8 million in Q4 2025.
Silence Therapeutics (SLN) Net Income (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Net Income data on file, last reported at -$15.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income rose 47.57% year-over-year to -$15.0 million; the trailing twelve-month figure through Mar 2026 stood at -$75.0 million (down 25.98% YoY), and the FY2025 full-year result was -$88.6 million, down 165.72% from the prior year.
- Net Income fell to -$15.0 million in Q1 2026, from -$11.8 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $24.3 million in Q4 2024 to a low of -$35.5 million in Q3 2024.
- A 3-year average of -$15.2 million and a median of -$19.8 million in 2024 frame the typical range for Net Income.
- Across the five-year window, Net Income sank 1134.0% in 2025 and surged 47.57% in 2026, its largest moves.
- Tracing SLN's Net Income over 3 years: stood at $24.3 million in 2024, then tumbled by 148.51% to -$11.8 million in 2025, then retreated by 27.08% to -$15.0 million in 2026.
- Business Quant data shows SLN's Net Income at -$15.0 million in Q1 2026, -$11.8 million in Q4 2025, and -$21.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -14.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.96 Mn |
| Dec 31, 2025 | -11.77 Mn |
| Sep 30, 2025 | -20.96 Mn |
| Jun 30, 2025 | -27.35 Mn |
| Mar 31, 2025 | -28.53 Mn |
| Dec 31, 2024 | 24.26 Mn |
| Sep 30, 2024 | -35.54 Mn |
| Jun 30, 2024 | -19.76 Mn |
| Mar 31, 2024 | -2.31 Mn |